Correlations Between Arrhythmias and Air Pollution in Patients With Pacemaker and ICD (ARIA)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Effect Group, Italy
ClinicalTrials.gov Identifier:
NCT01723761
First received: October 23, 2012
Last updated: April 2, 2013
Last verified: April 2013

October 23, 2012
April 2, 2013
April 2011
September 2013   (final data collection date for primary outcome measure)
  • incidence of atrial arrhythmias. [ Time Frame: 12- 24 months. ] [ Designated as safety issue: No ]
    The arrhythmic events that will occur during follow-up period, detected by remote monitoring or through other clinical evaluations, will be recorded and classified as follows: atrial fibrillation or atrial flutter, supraventricular tachycardia.
  • incidence of ventricular arrhythmias [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
    The arrhythmic events that will occur during follow-up period, detected by remote monitoring or through other clinical evaluations, will be recorded and classified as follows: ventricular tachycardia, ventricular fibrillation, premature ventricular beats.
Same as current
Complete list of historical versions of study NCT01723761 on ClinicalTrials.gov Archive Site
  • Mean heart rate [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
    Mean heart rate obtained by remote monitoring of pacemaker and ICDs.
  • Heart rate variability [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
    Measures of heart rate variability calculated by devices and obtained by remote monitoring.
  • Percentage of paced beats [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
    Percentage of paced beats will be measured by devices diagnostic and obtained via remote monitoring.
  • Mortality for myocardial infarction or heart failure. [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
  • Hospitalization for myocardial infarction or heart failure. [ Time Frame: 12-24 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Correlations Between Arrhythmias and Air Pollution in Patients With Pacemaker and ICD
Correlations Between Arrhythmias, Climatic Variables and Air Pollution in Patients With Pacemaker and ICD, Followed by Remote Monitoring.

It is a clinical, observational study to evaluate the correlations among arrhythmias, climatic variables and air pollution in patients with pacemaker and implantable defibrillator (ICD), followed by remote monitoring.

Purpose of the Study: The purpose of this study is to test the hypothesis that changes in climatic variables, such as temperature, pressure and humidity, and changes of particulate matter <10µ (PM10), particulate matter <2.5µ (PM2.5), ozone (O3), carbon monoxide (CO), sulfur dioxide (SO2), nitrogen dioxide (NO2), are associated with an increase of supraventricular and ventricular arrhythmias.

Objectives: The aim of this study is to determine whether changes in variables conditions affect the electrical stability of the myocardium in patients with pacemakers and ICDs.

Population: male and female subjects, aged ≥ 18 years, implanted by a dual-chamber pacemaker, ICD or biventricular ICD (ICD-CRT). A total of 500 subjects from 15 cardiology centers of the Veneto region will be included.

The primary objectives of this study are as follows:

  • Determine if the changes of temperature, pressure and humidity, are associated with an increase of atrial and ventricular arrhythmias.
  • Determine if the changes of air pollution (gas and particulate), are associated with an increase of atrial and ventricular arrhythmias.

The secondary objectives of the study are:

  • Determine if the changes of air pollution (gas and particulate), are associated with significant changes in mean heart rate, rate variability rate and the percentage of paced beats.
  • Determine whether changes in temperature, pressure or humidity, are associated with significant changes in mean heart rate, heart rate variability and the percentage of paced beats.
  • Determine if the changes of temperature, pressure and humidity, are associated with an increase in mortality or hospitalization for myocardial infarction or congestive heart failure.
  • Determine if the changes of air pollution (gas and particulate), are associated with an increase in mortality or hospitalization for myocardial infarction or congestive heart failure.

Study Design This is a prospective, observational study, which compares the occurrence of atrial and ventricular arrhythmias and changes in physiological parameters, with climatic variables and air pollution.

The study will include 500 subjects and will consist of two periods:

Screening: we will collect baseline characteristics of subjects in the clinical examination. The period recruitment will run for 12 months.

Follow-up: After written informed consent will be signed, subjects who meet the criteria for inclusion will be enrolled in the study and followed up for a minimum period of 12 months. The data obtained from the remote monitoring will be evaluated for the daily values ​​provided for the parameters considered in the study.

Periodical visits in pacemaker clinic will be scheduled at the discretion of the referring cardiologist of the center. The arrhythmic events that will occur in this period, detected by means of remote monitoring or through other clinical evaluations will be recorded. Atrial arrythmias: atrial fibrillation or atrial flutter, supraventricular tachycardia.

Ventricular arrhythmias: ventricular tachycardia, ventricular fibrillation, ventricular extrasystoles.

Physiological variables: average heart rate (24 hours and at rest), heart rate variability, the percentage of paced beats.

In addition, any changes in drug therapies and all clinically relevant events, will be recorded.

During the same period data from monitoring stations of ARPAV (Regional Agency for Environmental Prevention and Protection of Veneto Region) will be collected.

Climatic variables: temperature, humidity, atmospheric pressure. Parameters of air pollution: PM10, PM2.5, O3, CO, SO2, NO2. For each patient, the data from the monitoring station ARPAV of the urban area of ​​residence of the subject will be considered. The mean exposure level used in the analytical studies on the health effects is calculated on the average number of units active in the area. This number is usually of 2-3 units in large centers, while it is generally only 1 in small towns. The residents in centers without monitoring will be excluded from the study. The mean value is the best approximation ... to be continued page 6.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Males and females, aged ≥ 18 years of age who have been implanted with a dual-chamber pacemaker, an ICD or ICD-CRT.

Air Pollution
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
483
December 2013
September 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stable subjects,> 18 years, who have been implanted with a dual-chamber pacemaker, an ICD or ICD-CRT, compatible with remote monitoring systems, with daily transmission of data.

Exclusion Criteria:

  • Presence of heart failure clinically manifest.
  • Concomitant illness or a significant condition which severely limits the life expectancy.
  • Any medical or surgical condition that, at the discretion of the investigator, places the patient at higher risk for his participation in the study.
  • History of malignancy of any organ system in the last two years, whether treated or untreated, including leukemia and lymphoma (with the exception of basal cell carcinoma of the skin) if there is evidence of local recurrence of metastasis.
  • History of drug or alcohol abuse in the last 2 years.
  • Participation in another study of a drug or device within 30 days after randomization.
  • Inability to communicate and to comply with all such obligations including the unwillingness or inability to give an informed consent.
  • Residence in urban centers without environmental monitoring.
Both
19 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
NCT01723761
ARIAPOL 01
No
Effect Group, Italy
Effect Group, Italy
Not Provided
Principal Investigator: Gianfranco Buja, MD University of Padua
Effect Group, Italy
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP